The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
250 jobs Number of planned job creations
Announcement Date
7 March 2022
Employment effect (start)
1 March 2022
Foreseen end date
Description
GSK (GlaxoSmithKline), the British multinational pharmaceutical company and the biggest employer in the Belgian Region of Wallonia, is to create 250 new jobs. The company is looking for researchers to support the development of 20 new vaccines, but also for roles in production and export of existing vaccines (influenza, polio, meningitis). GSK has also launched a recruitment day.
Currently, GSK employs 9,000 people in Belgium. The company distributes around 600 million doses of vaccines in more than 160 countries.
Eurofound (2022), GlaxoSmithKline, Business expansion in Belgium, factsheet number 106468, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/106468.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
